additional survivors compared to immediate administration at 22 weeks. Overall, delaying administration of antenatal steroids by three weeks led to higher QALYS when compared to immediate treatment. However, there would be 10 more neonates with respiratory distress syndromes, 20 more intraventricular hemorrhage, and 11 more children with neurodevelopmental delay. With sensitivity analysis, we found that as long as the probability of survival at 25 weeks gestation is less than 81%, then delaying administration by three weeks remains the optimal strategy. CONCLUSION: Our results support that the optimal time for administration of antenatal corticosteroids in women with PPROM at 22 weeks is three weeks after presentation at 25 weeks gestation to reduce mortality and minimize morbidity. These findings can be used to counsel women presenting in the periviable period.
OBJECTIVE: Preterm delivery secondary to preeclampsia have severe neonatal complications, although incidences can be reduced with antenatal corticosteroid treatment. Despite their benefits, there is evidence that the effects of steroids decrease 7 days after treatment, thus the timing of administration following presentation impacts neonatal outcomes. The objective of this study was to use a decision analysis to determine the optimal time for steroid administration for women with severe preeclampsia at 22 weeks. STUDY DESIGN: A decision-analytic model was constructed using TreeAge software to compare neonatal mortality and morbidity following steroid treatment in a theoretical cohort of 1,000 women who present with severe preeclampsia at 22 weeks. The model compared administering steroids immediately at presentation (22 weeks), at 1 week (23 weeks), and at 2 weeks (24 weeks) following presentation. The outcomes of neonatal death, respiratory distress syndrome (RDS), intraventricular hemorrhage (IVH), and neurodevelopmental delay were assessed along with quality-adjusted life years (QALYs). All probabilities, utilities, and costs were derived from literature. Costs are expressed in 2018 US dollars with a willingness to pay threshold (WTP) set at $100,000/QALY. Deterministic and probabilistic sensitivity analyses were performed to interrogate model assumptions. RESULTS: In our theoretical cohort of 1,000 women who present with preeclampsia at 22 weeks, administering steroids one week after presentation resulted in 12 additional survivors compared to immediate treatment at 22 weeks and 163 more survivors compared to waiting until week 24. Giving steroids at 23 weeks gestation led to 16 fewer neonates with RDS, 32 fewer neonates with IVH, and 12 fewer children with neurodevelopmental delay. Overall, delaying administration of antenatal steroids by one week led to higher QALYS when compared to immediate treatment. With sensitivity analysis, we found that as long as the probability of survival at 23 weeks gestation is less than 55%, then delaying administration remains the optimal strategy.
CONCLUSION:
Our results support that the optimal time for administration of antenatal corticosteroids in women with severe preeclampsia at 22 weeks is one week after presentation at 23 weeks gestation to reduce morbidity and mortality. These findings can be used to counsel women presenting in the periviable period. OBJECTIVE: This study analyzes differences in maternal and neonatal outcomes from elective induction of labor (eIOL) at 39 weeks versus one additional week of expectant management in nulliparous women at community hospitals. STUDY DESIGN: We conducted a retrospective cohort study of singleton, vertex, nonanomalous deliveries in community hospitals in California between 2007 and 2011 using linked hospital discharge and vital statistics data (n¼252,107). We compared outcomes from eIOL, defined by the Joint Commission, at 39 weeks against one additional week of expectant management and delivery at 40 weeks. The maternal outcomes of interest were cesarean delivery, operative vaginal delivery, maternal blood transfusion, perineal tear, chorioamnionitis, and endomyometritis. Neonatal outcomes of interest were intrauterine fetal death, 5 minute Apgar less than 7, NICU admission, respiratory distress syndrome (RDS), hypoglycemia, hypoxic ischemic encephalopathy (HIE) and jaundice. Results were compared using chi square analysis and examined using multivariate logistic regression controlling for maternal age, comorbidities, ethnicity, education level, initiation of prenatal care in the first trimester, and insurance status. A p-value of less than 0.05 was used to indicate statistical significance. RESULTS: In our cohort of 252,107 deliveries, there were significant differences in the incidence of cesarean delivery, operative vaginal delivery, maternal transfusion, perineal tear, chorioamnionitis, endomyometritis in women who were electively induced at 39 weeks compared to those who received expectant management and delivered at 40 weeks. Rates of adverse neonatal outcomes of intrauterine fetal death and hypoglycemia were also significantly decreased when women were electively induced at 39 weeks. However, RDS, HIE and jaundice were not significantly different between the two groups. Logistic regression analysis indicated expectant management until 40 weeks significantly increased cesarean deliveries (OR 1.37, 95% CI 1.32-1.42) and operative vaginal deliveries (OR 1.0, 95% CI 1.02-1.15). CONCLUSION: The maternal and neonatal outcomes following birth are associated with the timing and management prior to delivery. These findings can be used to counsel women regarding the risks of maternal and neonatal complications from elective induction of labor and one additional week of expectant management. Newark Beth Israel Medical Center, Newark, NJ OBJECTIVE: To determine if latency antibiotic regimens including azithromycin versus erythromycin has an impact on latency period or rates of chorioamnionitis. STUDY DESIGN: : We conducted a prospective observational cohort study and followed all women receiving latency antibiotic treatment involving either azithromycin or erythromycin in the context of preterm premature rupture of membranes. Choice of regimen was determine by attending physician preference. The azithromycin group consisted of azithromycin 1g PO once and ampicillin 2g every 6 hours IV for 48 hours followed by 5 days of amoxicillin 250mg every 8 hours PO for 5 days. The erythromycin group consisted of erythromycin 250mg and ampicillin 2g every 6 hours IV for 48 hours followed by amoxicillin 250mg and erythromycin 500mg every 8 hours PO for 5 days. Primary outcomes were duration of latency period and delivery without development of chorioamnionitis. Patients were excluded if latency antibiotic regimen included combinations apart from those defined. Patients were excluded if final pathological analysis of placenta did not confirm chorioamnionitis. RESULTS: The study included 101 patients, with 47 receiving azithromycin regimen and 54 receiving erythromycin. No statistical difference was noted in latency period, cesarean delivery rate, or development of neonatal sepsis in either crude or adjusted analysis. When compared with the erythromycin regimen group, the azithromycin regimen group had lower rates of chorioamnionitis 27.9% (95% CI 25.1-31.3) versus 34.9% (95% CI 29.8-37.3), p ¼ 0.021. In crude analysis, compared to erythromycin regimen group, the azithromycin regimen group had lower risk of chorioamnionitis (RR 0.58, 95% CI 0.11-0.87, p ¼ 0.01). After adjusting for BMI, diabetes mellitus, gestational blood pressure >140/90, group b-Streptococcus status, race, advanced maternal age (>34 y), and parity, this lower risk was consistently demonstrated (RR 0.43, 95% CI 0.18-0.71, p ¼ 0.045). CONCLUSION: This is the first prospective study to evaluate difference in latency antibiotic regiments including either azithromycin or erythromycin. Our study suggests that latency antibiotic regimens substituting azithromycin for erythromycin have a lower risk of chorioamnionitis and thus can be considered a superior option in the treatment of preterm premature rupture of membranes. OBJECTIVE: Periodontal disease and dental abscesses are established risk factors for preterm labor. Embryological origins of respective teeth are through to influence the organ systems of their associated origin. This study seeks to evaluate if periodontal disease/dental abscesses of those teeth associated embryologically with the female reproductive organs, number 7-10 or 23-26, is associated with adverse labor outcomes as compared to other locations. STUDY DESIGN: We conducted a retrospective cohort study and reviewed medical charts and dental records on all women diagnosed with periodontal disease/dental abscesses in the third trimester of pregnancy at our academic institution and affiliated dental clinic. Inclusion criteria included pregnant women 18-55 years old diagnosed with dental abscess with adequate dental records, gestational age >34 weeks gestational age, and no other diagnosis leading to preterm labor. The primary outcome evaluated was the development of preterm labor with known periodontal disease/dental abscess in the third trimester. RESULTS: The study included 31 patients, 16 patients with periodontal disease/dental abscesses involving teeth number 7-10 or 23-26, and 15 with periodontal disease/dental abscesses of other locations. When compared with the teeth of other locations, periodontal disease/dental abscess involving teeth number 7-10 or 23-26 had higher incidence of preterm labor 15.1% (95% CI 11.3-19) versus 8.2% (95% CI 5.5-11.6), p ¼ 0.044. In crude analysis, compared with the teeth of other locations, periodontal disease/ dental abscess involving teeth number 7-10 or 23-26 had higher risk of preterm labor (RR 1.66, 95% CI 1.13-1.99, p ¼ 0.01). After adjusting for BMI, diabetes mellitus, gestational blood pressure >140/90, group b-Streptococcus status, race, advanced maternal age (>34 y), type of previous cesarean scar (low transverse, classical, or unknown) and parity, this risk was consistently demonstrated (RR 1.31, 95% CI 1.08-1.55, p ¼ 0.05). CONCLUSION: Pregnant women in the third trimester with dental abscesses involving teeth numbers 7-10 or 23-26 have an increased
